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CORRECTION
Correction: The Effect of Ginger (Zingiber
officinale) on Platelet Aggregation: A
Systematic Literature Review
Wolfgang Marx, Daniel McKavanagh, Alexandra L. McCarthy, Robert Bird, Karin Ried,
Alexandre Chan, Liz Isenring
Table 1 appears incorrectly in the published article. Please see the corrected Table 1 here.
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Table 1. Extraction table of reviewed clinical trials.
Author/
Date
Bordia et al. 1997 Bordia et al.
1997
Janssen et al.
1996
Jiang et al. 2004 Lumb. 1994 Srivastava
1989
Verma et al. 1993 Young et al.
2006
Study
design
Placebo-
controlled trial
Placebo-
controlled trial
Randomised,
placebo-
controlled
cross-over trial
Randomized, open
label, three-way
cross-over trial
Randomised, double-
blinded placebo-
controlled cross-over
trial
Open-label
single-arm
trial
Randomised
placebo-
controlled trial
Cross-over
trial
Sample
Size
N = 60 N = 20 N = 18 N = 12 N = 8 N = 7 N = 20 N = 10 for
each group
Total study
period:
3 months. One day 6 weeks (3x2
weeks)
3x13 days, 14
days washout
period between
each study period.
2x1 day, at least 14
days washout period.
7 days 14 days, high-
calorie diet for
first 7 days, high-
calorie diet and
ginger/placebo
consumed for
next 7 days.
72 days, 4x
washout
period of 7–10
days, 5x7 days
intervention
consumed
Population Patients with
confirmed
myocardial
infarction
Patients with
confirmed
myocardial
infarction
Healthy
volunteers
Healthy male
volunteers
Healthy male
volunteers
Health female
volunteers
Health male
volunteers
Healthy &
Hypertensive
volunteers
Outcomes
measured
at:
Baseline, 1.5
months and 3
months.
Outcomes
measured at:
baseline, 4
hours post-
consumption
Outcomes
measured at
day 12 and 14
of each study
period.
Outcomes
measured at
multiple time
points, starting 2
days pre-warfarin
consumption to 7
days post-
consumption
Outcomes measured
immediately before,
3h, and 24h post
consumption of ginger
Outcomes
measured at
baseline and
7 days post-
consumption
Outcomes
measured at
baseline, 7, and
14 days
Outcomes
measured at
baseline and 7
days post-
consumption
for each
intervention
Intervention Dose: 4g per day
of
unstandardized
capsules
Dose: 10g single
dose of
unstandardized
capsules
Dose: 15g raw
& 40g cooked
ginger placebo,
once per day.
Contained
within 125g
custard
Dose: 3.6g
(3x0.4g, thrice per
day) of
unstandardized
capsules.
Consumed with 25
mg dose of rac-
warfarin,
consumed once
per study period.
Dose: 2g (4x500mg)
dried ginger per day of
unstandardized
capsules
Dose: 5g raw
ginger per day
Dose: 5g
(4x625mg, twice
per day) dry
ginger powder of
Unstandardized
capsules.
Consumed with
100g (2x50g)
butter, 2 cups of
milk, 8 slices of
bread.
Dose: 1g dried
ginger per day,
either alone or
in combination
with 10mg
nifedipine
Outcome Platelet
aggregation
Platelet
aggregation
Thromboxane
B2 production
(Payton
Aggregation
Module)
Platelet
aggregation
Platelet aggregation Platelet
thromboxane
B2 production
Platelet
aggregation
Platelet
aggregation
- Agonist(s): ADP
and Epi
- Agonist(s):
ADP and Epi
- Agonist(s): AA - Agonist(s): AA, ADP,
collagen, ristocetin
- Agonist(s): ADP
and Epi
- Agonist(s):
ADP, Epi,
collagen
- Method
(Device, if
reported):
Turbidimetric
- Method
(Device, if
reported):
Turbidimetric
- Method (Device,
if reported):
Turbidimetric
(Chrono-log)
- Method (Device, if
reported): Electrical
impedance (Chrono-
log)
- Method (Device,
if reported):
turbidimetric
(ELVI-840)
- Method
(Device, if
reported):
Turbidimetric
(Chronolog
560)
Fibrinogen INR Bleeding time
Fibrinolytic
activity
Plasma warfarin
enantiomer protein
binding & warfarin
enantiomer
concentrations
Platelet count
Urinary S-
7-hydroxywarfarin
Thromboelastography
(Continued)
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Table 1. (Continued)
Results Ginger had no
significant effect
on both
measures of
aggregation
Reduction of
both measures
of platelet
aggregation
when compared
to placebo
(p<0.05).
Both types of
ginger had no
significant
effect on
maximum
thromboxane
B2 production
(p = 0.616)
No significant
changes in any
outcome
No significant
changes in any
outcome at any time
point.
Ginger
consumption
resulted in a
37% inhibition
of
thromboxane
B2 production
(p<0.01).
Ginger
significantly
reduced platelet
aggregation using
both agonists
when compared
to placebo group
(p<0.001).
Ginger
combined with
nifedipine
resulted in a
significant
decrease in
platelet
aggregation
(p<0.001).
Ginger alone
had no
significant
effect.
Country India India Netherlands Australia UK Denmark India Taiwan
Level of
evidence
III-1* III-1 II III-1 II III-3 II III-2
Comment Ginger had no
significant effect
on blood lipids or
blood sugar.
Results relating
to fenugreek
excluded from
table. No mention
of randomisation.
P value not
reported.
This study was
detailed in same
manuscript as
previous study.
No placebo group
was included in
study. Results
relating to ginkgo
group excluded
from table. P value
not reported.
Results
relating to
onion group
excluded from
table.
Platelet
aggregation
reduced close to
baseline but did
not decrease
further.
No placebo
group. Unclear
if participants
were blinded.
Abbreviations: AA, arachidonic acid; ADP, Adenosine Diphosphate; Epi, epinephrine; INR, International Normalised Ratio; TxB2, Thromboxane B2;.
* Indicates some study details were missing and that scoring was based on details available.
doi:10.1371/journal.pone.0143675.t001
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